MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
0.6649
-0.0195
-2.85%
Opening 12:54 05/30 EDT
OPEN
0.6791
PREV CLOSE
0.6844
HIGH
0.6880
LOW
0.6501
VOLUME
299.55K
TURNOVER
125.36K
52 WEEK HIGH
28.86
52 WEEK LOW
0.4601
MARKET CAP
12.70M
P/E (TTM)
-0.0279
1D
5D
1M
3M
1Y
5Y
Jaguar Announces Over-Enrollment In Its Pivotal Phase 3 OnTarget Trial Of Crofelemer For Prophylaxis Of Cancer Therapy-Related Diarrhea
Benzinga · 5d ago
Jaguar Health Says It Over-Enrolled Study Evaluating Crofelemer in Cancer Therapy-Related Diarrhea
Jaguar Health Says It Over-Enrolled Study Evaluating Crofelemer in Cancer Therapy-Related Diarrhea
MT Newswires · 5d ago
Jaguar Health Inc: Current report
Press release · 05/19 17:01
Nasdaq Rises 75 Points; Tower Semiconductor Posts Upbeat Q1 Results
Benzinga · 05/15 18:47
Filament Health's Q1 2023 Financial Results, Material Uncertainty On The Horizon
Benzinga · 05/15 18:15
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 05/15 17:45
Crude Oil Rises 1.5%; Athenex Shares Plummet
Benzinga · 05/15 16:00
BRIEF-Jaguar Health Inc Reports Qtrly Loss Per Share $2.39
Reuters · 05/15 12:40
More
About JAGX
Jaguar Health, Inc. is a commercial-stage pharmaceutical company. The Company is focused on developing plant-based, sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea. It operates through two segments: human health and animal health. Human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. Animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. Its Canalevia-CA1 is used for chemotherapy-induced diarrhea in dogs. Its subsidiary includes Napo Pharmaceuticals, Inc., which focuses on developing and commercializing plant-based human pharmaceuticals.

Webull offers kinds of Jaguar Health Inc stock information, including NASDAQ:JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.